Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites

BACKGROUND: Substandard medicines, whether the result of intentional manipulation or lack of compliance with good manufacturing practice (GMP) or good distribution practice (GDP), pose a significant potential threat to patient safety. Spontaneous adverse drug reaction reporting systems can contribut...

Descripción completa

Detalles Bibliográficos
Autores principales: Juhlin, Kristina, Karimi, Ghazaleh, Andér, Maria, Camilli, Sara, Dheda, Mukesh, Har, Tan Siew, Isahak, Rokiah, Lee, Su-Jung, Vaughan, Sarah, Caduff, Pia, Norén, G. Niklas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544545/
https://www.ncbi.nlm.nih.gov/pubmed/25687792
http://dx.doi.org/10.1007/s40264-015-0271-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544545/
https://www.ncbi.nlm.nih.gov/pubmed/25687792
http://dx.doi.org/10.1007/s40264-015-0271-2

Ejemplares similares